Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Simó

Showing results (91-100 of 358) with videos related to

Pageof 36
Sort By:
International Journal of Molecular Sciences|January 8, 2023
Transcriptomic Analysis Reveals That Retinal Neuromodulation Is a Relevant Mechanism in the Neuroprotective Effect of Sitagliptin in an Experimental Model of Diabetic RetinopathyHugo Ramos, Patricia Bogdanov, Rafael Simó, et al.
Diabetes Care|December 25, 2003
Hepatocyte growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy: its relationship with vascular endothelial growth factor and retinopathy activityRafael Simó, Albert Lecube, José García-Arumí, et al.
The American Journal of Gastroenterology|July 10, 2007
Glucose abnormalities are an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis CAlbert Lecube, Cristina Hernández, Rafael Simó, et al.
Diabetes Care|October 27, 2006
Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infectionRafael Simó, Albert Lecube, Joan Genescà, et al.
Experimental Eye Research|August 8, 2009
Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cellsMarta Villarroel, Marta García-Ramírez, Lidia Corraliza, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2011
Measuring permeability in human retinal epithelial cells (ARPE-19): implications for the study of diabetic retinopathyMarta Garcia-Ramírez, Marta Villarroel, Lídia Corraliza, et al.
Metabolism: Clinical and Experimental|May 25, 2020
Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysisJian-Bo Zhou, Xingyao Tang, Min Han, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 18, 2003
Effects of hypolipidemic treatment on serum markers of vascular inflammation in dyslipidemic menCristina Hernández, Albert Lecube, Gloria Barberá, et al.
Antioxidants (Basel, Switzerland)|September 15, 2020
Beneficial Effects of Glucagon-Like Peptide-1 (GLP-1) in Diabetes-Induced Retinal Abnormalities: Involvement of Oxidative StressHugo Ramos, Patricia Bogdanov, Joel Sampedro, et al.
Journal of Alzheimer'S Disease : JAD|March 3, 2025
Revisiting the Montreal Cognitive Assessment in a European cohort of elderly living with type 2 diabetesNatasa Popovic, Noemi Lois, Santiago Pérez-Hoyos, et al.
Pageof 36

Showing results (91-100 of 358) with videos related to

Sort By:
Pageof 36
International Journal of Molecular Sciences|January 8, 2023
Transcriptomic Analysis Reveals That Retinal Neuromodulation Is a Relevant Mechanism in the Neuroprotective Effect of Sitagliptin in an Experimental Model of Diabetic RetinopathyHugo Ramos, Patricia Bogdanov, Rafael Simó, et al.
Diabetes Care|December 25, 2003
Hepatocyte growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy: its relationship with vascular endothelial growth factor and retinopathy activityRafael Simó, Albert Lecube, José García-Arumí, et al.
The American Journal of Gastroenterology|July 10, 2007
Glucose abnormalities are an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis CAlbert Lecube, Cristina Hernández, Rafael Simó, et al.
Diabetes Care|October 27, 2006
Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infectionRafael Simó, Albert Lecube, Joan Genescà, et al.
Experimental Eye Research|August 8, 2009
Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cellsMarta Villarroel, Marta García-Ramírez, Lidia Corraliza, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 30, 2011
Measuring permeability in human retinal epithelial cells (ARPE-19): implications for the study of diabetic retinopathyMarta Garcia-Ramírez, Marta Villarroel, Lídia Corraliza, et al.
Metabolism: Clinical and Experimental|May 25, 2020
Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysisJian-Bo Zhou, Xingyao Tang, Min Han, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|March 18, 2003
Effects of hypolipidemic treatment on serum markers of vascular inflammation in dyslipidemic menCristina Hernández, Albert Lecube, Gloria Barberá, et al.
Antioxidants (Basel, Switzerland)|September 15, 2020
Beneficial Effects of Glucagon-Like Peptide-1 (GLP-1) in Diabetes-Induced Retinal Abnormalities: Involvement of Oxidative StressHugo Ramos, Patricia Bogdanov, Joel Sampedro, et al.
Journal of Alzheimer'S Disease : JAD|March 3, 2025
Revisiting the Montreal Cognitive Assessment in a European cohort of elderly living with type 2 diabetesNatasa Popovic, Noemi Lois, Santiago Pérez-Hoyos, et al.
Pageof 36